2 April 2013
Catapult announces further investment in nanoTherics
Catapult has participated in a £400,000 further investment round in Staffordshire based nanoTherics alongside Mercia Fund Management and other existing shareholders.
nanoTherics develops and sells magnetic nanoparticle-based instrumentation and associated products for the life science research industry. Its innovative products are transforming the research practices in industry and academia in respect of investigations into cancer and gene-related diseases and disorders.
Jonathan Earl, who led the transaction for Catapult, comments “this investment round is to support Carlton Jones, the company’s new CEO, and the wider team in the expansion of sales infrastructure and development of further products as the business continues to expand.”